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Abstract
Introduction: Histotripsy is a nonthermal, noninvasive, pulsed ultrasound technology that homogenizes tissue
within the targeted volume. From previous experiments, it appeared that the resultant fibrotic response from
histotripsy was limited compared with the typical tissue response seen after thermoablation. The objective of
this study was to characterize the inflammatory response and quantify patterns of collagen deposition 6 weeks
after in vivo canine prostate histotripsy.
Methods: Histotripsy was applied to the left half of eight canine prostates to produce an intraparenchymal zone
of tissue homogenization. Six weeks after treatment, prostates were harvested, sectioned, and stained with
hematoxylin and eosin for histologic evaluation, CD3, CD20, and Mac387 immunohistochemistry to charac-
terize the inflammatory components, and picrosirius red staining to identify collagen.
Results: Seven of eight treated prostates exhibited only minimal residual inflammation. Visual microscopic
analysis of picrosirius red slides revealed a band of dense collagen (0.5mm wide) immediately adjacent to the
cavity produced by histotripsy. This was surrounded by a second band (1mm wide) of less dense collagen
interspersed among glandular architecture. A lobar distribution of epithelial atrophy and basal cell hyperplasia
reminiscent of periurethral glands and ducts was apparent surrounding the margin of the treatment cavities.
Tissue loss (-31%) was apparent on the treated side of all prostates while four demonstrated a net decrease in
collagen content.
Conclusions: In vivo histotripsy of canine prostate produced a decrease in prostate volume coupled with a
limited inflammatory and fibrotic response. A narrow (1.5mm) band of fibrosis around the empty, re-
epithelialized treatment cavity was observed 6 weeks after treatment. In four cases, an overall reduction in
collagen content was measured. Further studies are planned to correlate these histologic findings with alteration
in mechanical tissue properties and to explore histotripsy strategies for treatment of benign prostatic hyperplasia
that optimize tissue volume removal with minimization of fibrosis.
Introduction
F ibrosis within the prostate has recently been impli-cated as a contributing factor in the etiology of lower
urinary tract symptoms (LUTS) from benign prostatic hy-
perplasia (BPH).1,2 Conventional teaching holds that me-
chanical obstruction from enlarging prostatic adenoma (static
factor) and increased smooth muscle tone (dynamic factor)
are the source of LUTS. It is believed, however, that exces-
sive myofibroblast activity within the prostate and increased
collagen deposition increases tissue stiffness and thereby
decreases urethral function.1 Fibrosis has also been linked to
organ dysfunction and disease of the pancreas, lungs, liver,
kidney, and bowel.3–5
Recent pilot studies analyzing prostatic tissue support an
association between collagen content/prostatic fibrosis and
LUTS in specimens obtained from radical prostatectomy.1,2
Additional research in a mouse model has bolstered the ev-
idence supporting a causative relationship between fibrosis
and LUTS.6 It therefore seems plausible that treatment mo-
dalities that debulk overgrown adenomatous tissue and/or
reduce fibrosis, may provide the best opportunity for LUTS
improvement.
Histotripsy is a noninvasive ablative acoustic technology
that destroys targeted tissue by inducing acoustic cavitation
(microbubble formation) to mechanically homogenize cellular
and connective (collagen) components of tissue, without pro-
ducing thermal coagulative necrosis. As a result, histotripsy
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can be tightly confined with only a narrow marginal zone of
sublethal damage. The feasibility of histotripsy tissue ho-
mogenization (producing a transurethral resection of the
prostate [TURP]-like defect) has been previously demon-
strated in canine models.7–9 Typically, the margin of the
treatment cavity exhibited only a limited fibrotic response
and was repopulated with urothelium within 3 to 4 weeks of
histotripsy.10,11
The current study was conducted to explore the fibrotic
response after histotripsy. Specifically, we sought to char-
acterize the inflammatory response and quantify patterns of
collagen deposition 6 weeks after in vivo canine prostate
histotripsy.
Methods
Eight intact male mongrel dogs were used for this study
with the approval of the Institutional Animal Care and Use
Committee. The canine subjects were prepared for histotripsy
as reported previously.12 Briefly, after administration of an-
tibiotic prophylaxis and analgesia, canines were anesthetized,
intubated, and maintained under inhalational anesthesia. The
suprapubic region was shaved and a soap suds enema per-
formed to evacuate the rectum before positioning supine on
the procedural table. Transrectal ultrasonography (TRUS)
using a Logiq P6 US scanner and ERB probe (GEHealthcare,
Waukesha, WI) in a custom holder facilitated targeting and
provided image feedback during treatment.
The histotripsy transducer, an 11· 14 cm oval-shaped
piezoceramic composite array (750 kHz frequency, 10 cm
focal length; Imasonic, Inc., Voray-sur-l’Ognon, FR), gen-
erated an approximate 3 · 3 · 8mm bubble cloud. This de-
vice was suspended from a three-axis computer-controlled
positioning system (MATLAB, MathWorks, Natick, MA)
above the abdomen with acoustic coupling achieved by
placing the histotripsy transducer in a bolus of degassed water
contained within a thin plastic membrane on the shaved
abdomen (Fig. 1).
Each dog underwent histotripsy treatment by sequential
targeting of a grid of distinct points (spaced by 6–9mm)within
the left hemiprostate to avoid the urethra. The number of
distinct target points varied (5–11), depending on the prostate
size and shape. Each target point was treated for 120 seconds at
a pulse repetition frequency of 500Hz (60,000 pulses). After
treatment, canine subjects were monitored with daily veteri-
nary evaluations assessing hematuria, urinary retention, pain,
and changes in dietary pattern or behavior. Flexible cystour-
ethroscopy (8.2F Dur-8 flexible ureteroscope) was performed
to inspect the bladder and prostatic urethra immediately post-
treatment and weekly thereafter. TRUS imaging was per-
formed to assess for treatment effect weekly.
Six weeks after treatment, the canine subjects were sacri-
ficed, and the prostates harvested. Two prostates obtained
from untreated subjects in an unrelated study were used as
controls. Specimens were fixed in formalin for 1 week, cut
into 5mm thick slices, dehydrated with 24% ethanol, and
embedded in paraffin. Transverse sections (5 lm thick) were
cut at 1mm increments through the prostate, mounted, and
stained with hematoxylin and eosin for histologic evaluation.
CD3, CD20, and Mac387 immunohistochemistry were per-
formed to characterize the inflammatory components, and
picrosirius red staining was performed to identify collagen.
Each half-prostate (divided by a vertical midline through the
urethra) was examined and inflammation quantified on a 0-4
scale: 0–no inflammation, 1–rare interstitial inflammation, 2–
rare inflammatory foci (including follicle formation), 3–
frequent inflammatory foci, and 4–diffuse confluent inflam-
mation. Histopathologic evaluation was performed by a
board certified anatomic pathologist with subspecialty ex-
pertise in genitourinary pathology (SAT).
Imaging methods, similar to those reported by Juodziu-
kyniene and associates,13 were used to quantify collagen.
Microscopic images of picrosirus red stained slides were
captured at 20x magnification (pixel size 3.7 lm), and images
of whole transverse prostate images at 2400 dots per inch
(dpi) resolution (pixel size 10.6 lm) were acquired with a
flatbed scanner. Red pixels were categorized as containing
collagen. ‘‘Collagen content’’ was defined as the area occu-
pied by red pixels and ‘‘collagen density’’ as the percentage
of red pixels within each defined region of interest.
FIG. 1. Apparatus for
canine prostate histotripsy
treatment. An anesthetized
canine is positioned supine
with transrectal ultrasonog-
raphy probe inserted in the
rectum. The histotripsy ther-
apy transducer suspended
over the shaved abdomen is
positioned within the de-
gassed water bath for acous-
tic coupling when delivering
energy to the prostate.
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The 20x magnified images were captured at eight locations
along the perimeter of the treatment cavities (the 3, 6, 9, and
12 o’clock locations and the associated intermediate loca-
tions) to assess the margin of the treatment cavity and im-
mediate adjacent tissue. The images taken from the flatbed
scanner encompassed the entire transverse section of the
prostate and were used to macroscopically compare the
treated and control (untreated) halves of each prostate that
were segmented by tracing the vertical anatomic midline
through the center of the urethra. Treatment cavities, devoid
of tissue, were excluded from the image analysis (Fig. 2).
Results
In vivo canine histotripsy produced a cavitation bubble
cloud, visualizedwithin the prostate and monitored with TRUS
imaging, in all cases. There were no treatment-related com-
plications during or after treatment. Weekly TRUS assessment
revealed development of anechoic cavities within the targeted
prostate volumes in each left hemiprostate.
On histologic examination, the treatment side of each
prostate exhibited a vacuous cavity that corresponded to the
histotripsy treatment volume. These cavities were epithelia-
lized and demonstrated urothelium with squamous metapla-
sia. A narrow band of loose fibromuscular stroma (1.5mm
width [range: 0.5–2.6mm]) was present surrounding each
treatment cavity (Fig. 3). On high power, the fibromuscular
stroma band was composed of two concentric fibrotic bands.
The average collagen density was found to be 85% in the
inner band and 75% in the outer band (Table 1).
The surrounding prostate glands showed lobular areas of
epithelial atrophy and basal cell hyperplasia interspersed
with unremarkable prostate glands, which varied across
cases. These areas of atrophy/basal cell hyperplasia were
reminiscent of periurethral glands and ducts (Fig. 4). No
specific relationship between histotripsy treatment and in-
flammation was apparent. Areas of atrophy/basal cell hy-
perplasia adjacent to histotripsy cavities had mildly increased
interstitial chronic inflammation, as is appreciable in basal
cell hyperplasia in other contexts.
FIG. 2. A 2400 dots per
inch scan of a prostate sec-
tion from subject 2 stained
with picrosirius red (left) for
collagen identification. The
histotripsy treatment cavity is
evident in the left hemi-
prostate. The red dots define
the region of interest used to
calculate the tissue collagen
density and tissue area. The
empty treatment lesion was
excluded from the region of
interest. A binary, black and
white rendering (right) of the
treated hemiprostate is shown
with collagen containing
pixels displayed as white.
FIG. 3. Representative portion of a 20 · magnified image
displaying the histotripsy treatment cavity as well as extent
of the surrounding inner and outer fibrotic bands, designated
on the image.
Table 1. Characterization of Collagen
Deposition/Fibrosis Surrounding
Histotripsy Treatment Cavities
Collagen band width
Collagen density
Subject
Inner
(mm)
Outer
(mm)
Total
(mm) Inner Outer
1 0.3 0.4 0.7 84% 50%
2 0.3 0.9 1.3 91% 81%
3 0.6 1.3 1.9 87% 84%
4 0.5 1.6 2.2 73% 66%
5 0.5 1.3 1.8 96% 88%
6 0.3 0.6 0.9 92% 89%
7 0.1 0.4 0.5 97% 90%
8 1.3 1.4 2.6 59% 56%
Average 0.5 1.0 1.5 85% 75%
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The contralateral untreated side of each prostate demon-
strated no appreciable effect from histotripsy and appeared
similar to control prostate specimens. The control prostates
and both treated and untreated sides of the experimental
prostates showed predominantly mild interstitial chronic in-
flammation (B-cells, T-cells, and plasma cells) with rare
lymphoid follicles. In a single case (subject 8), the histotripsy
cavity, which communicated with the urethra, had features of
a prostatic abscess, including intraepithelial acute inflam-
mation, epithelial ulceration, markedly increased macro-
phages, acute and chronic (B-cell, T-cell, and plasma cells)
inflammation.
Tissue loss was visually apparent on the treated side of
each prostate (Fig. 5). Comparison of cross-sectional areas of
the treated and untreated halves of each prostate revealed an
average of 1.5 cm2 (range 0.3–3.1 cm2) less prostate tissue on
each treated half. Assuming pretreatment symmetry of each
prostate, this represents amean 31% loss of tissue area (Table 2).
Four of the histotripsy-treated prostate halves demonstrated
a net increase in collagen content, while four demonstrated
a net decrease in collagen content (range - 21% to+ 33%).
Although histotripsy treatment was delivered to the pros-
tate with the intent of ‘‘sparing’’ the urethra (i.e., producing
zones of homogenate that would be resorbed rather than drain
via the urethra), in three cases (subjects 3, 7, 8) the treatment
cavity was seen to communicate with the urethra (Fig. 6). In
subject 7, the treatment cavity was within 1mm of the ure-
thral lumen with disruption of periurethral tissue and was
considered to have been in communication in an adjacent
tissue plane. In the other five cases, the periurethral smooth
muscle and connective tissue appeared intact with at least
2mm tissue thickness between the treatment cavity and
urethral lumen (Figs. 2, 5).
Discussion
Histotripsy destroys tissue by mechanical means and pro-
duces tissue liquefaction. In this study, seven of eight subjects
exhibited only minimal residual inflammation 6 weeks after
treatment equivalent to baseline. Tissue destruction was ap-
parent by an empty reepithelialized treatment cavity sur-
rounded by a thin band of fibrosis. On the treated half of each
prostate, a pattern of epithelial atrophy and basal cell hyper-
plasia was noted, which appeared reminiscent of conven-
tional periurethral glands/ducts. In contrast, thermoablative
modalities (transurethral needle ablation [TUNA], microwave
therapy, high intensity focused ultrasound [HIFU], intersti-
tial laser, etc.) are designed to heat tissue to cause immediate
cell death and protein coagulation (histology coagulation
FIG. 4. Representative histopathology of histotripsy-
treated canine prostate. (A) A composite image of a histo-
tripsy-treated canine prostate (subject 7). Anterior (Ant.)
and posterior (Post.) are indicated, along with the treated
and untreated sides. The urethra (U) and cavitation cavity
(C) are noted. Minimal interstitial inflammation was noted
in the treated and untreated sides in this subject. Indicated
areas shown in dashed black and green boxes are shown as
insets in B and C. (B) The reepithelialized cavitation cavity
is surrounded by fibromuscular stroma similar in appearance
to that surrounding the urethra. (C) Foci of atrophic glands
and basal cell hyperplasia surround the cavitation cavity,
reminiscent of periurethral ducts/glands. In addition, areas
of unremarkable prostate glands were also adjacent to the
cavitation cavity. Higher power view of atrophy and basal
cell hyperplasia with surrounding minimal interstitial chronic
inflammation is shown in the inset. Original magnifica-
tions 1.25· (A), 4· (B), 10· (C), and 20· (inset of C).
FIG. 5. This 2400 dots per inch scan of a picrosirius red
stained prostate section demonstrates a partially collapsed
histotripsy treatment cavity and tissue volume loss on the
left side of the prostate compared with the untreated right
side of the prostate. The measured cross-sectional tissue
area of the left hemiprostate was 2.4 cm2 less than the right.
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necrosis).14 This generates an inflammatory response that
commonly leads to dense fibrosis and scarring.15
In a comprehensive review of microwave, TUNA, HIFU,
and interstitial laser ablation treatment for BPH, Larson and
colleagues16 describe histologic findings of devitalized tissue
with a border of fibrosis and granulation tissue. In a study of
10 men with BPH who underwent TUNA, dense fibrosis or
scarring with adjacent areas of squamous metaplasia was
found in the three men who needed subsequent TURP.17
Fibrosis was also seen in several studies of thermal ablation
of prostate tissue in caninemodels. One study of radiofrequency
ablation demonstrated dense char within the prostate treatment
areas immediately after treatment—histologically consistent
with coagulative necrosis.18 Similarly, histologic analysis of
canine prostates harvested 0 to 12 weeks after HIFU treatment
revealed discolored lesions of tissue coagulative necrosis and
hemorrhage, with an inflammatory response, eventually form-
ing a cystic cavity or region of fibrosis and scarring.19
In this study, the overall extent of collagen deposition and
fibrosis after histotripsy appeared to be less than what has
been described for thermoablative modalities. The net change
in collagen content after histotripsy is likely the summation
of several competing factors. Some collagen is destroyed
with tissue homogenization, evidenced by a vacuous treat-
ment cavity. There appears to be collagen deposition sur-
rounding the treatment cavity, although only in a narrow band
(1.5mm). Beyond this zone there was marked tissue volume
loss (-31%) with apparent consolidation of preexisting col-
lagen and preferential shrinkage of the usual glandular epi-
thelial component. In four cases there appeared to be net loss
of collagen and in four cases a net increase of collagen within
the treated half of each prostate.
These results suggest that in certain cases, it may be pos-
sible to decrease collagen content within the prostate, which
can be hypothesized to lead to decreased tissue stiffness and
improved urethral compliance. Further work to test this hy-
pothesis is planned and will include tissue measures of
stiffness (Young’s modulus) both physically at prostate har-
vest and nondestructively with new methods of prostate tis-
sue ultrasound elastography. In addition, the clinical
significance of changing the mechanical properties of the
prostate needs to be assessed with clinically meaningful ur-
odynamic measures and ultimately assessment of LUTS.
This initial pilot study was limited by several factors in-
cluding small sample size. Ideally, a model system less
subject to prostate tissue heterogeneity is needed. Even un-
treated control prostate specimens exhibited marked hetero-
geneity of collagen density and inflammation, which is
consistent with the known histologic variability of BPH. To
overcome this limitation, only the left half of each prostate
Table 2. Comparison of the Treated and Untreated Half of Each Prostate and Control Data
Treated half Untreated half
Subject
Area
(cm2)
Inflam.
score
Collagen
content (cm2)
Collagen
density (%)
Area
(cm2)
Inflam.
score
Collagen
content (cm2)
Collagen
density (%)
Change in
area (cm2)
Change in
collagen
content (cm2)
1 3.4 1 1.0 31 4.8 1 0.9 19 - 1.4 [ - 29%] 0.1 [11%]
2 3.0 2 1.2 38 3.8 2 0.9 24 - 0.8 [ - 21%] 0.3 [33%]
3 2.5 2 1.1 43 3.7 2 1.4 38 - 1.2 [ - 32%] - 0.3 [ - 21%]
4 3.0 1 1.2 42 6.1 2 1.1 18 - 3.1 [ - 51%] 0.1 [9%]
5 4.6 2 2.0 42 7.0 3 2.1 30 - 2.4 [ - 34%] - 0.1 [ - 5%]
6 5.8 3 1.8 32 7.6 3 1.7 22 - 1.8 [ - 24%] 0.1 [6%]
7 2.5 0 1.9 79 2.8 1 2.1 73 - 0.3 [ - 11%] - 0.2 [ - 10%]
8 1.8 2 1.4 75 2.8 4 1.7 62 - 1.0 [ - 36%] - 0.3 [ - 18%]
Mean 3.3 1.6 1.4 48 4.8 2.2 1.5 36 - 1.5 [ - 31%] - 0.1 [ - 7%]
C1 right 4.4 3 2.1 49
C1 left 4.6 3 2.5 55
C2 right 4.9 2 1.8 36
C2 left 4.9 2 1.9 40
FIG. 6. 2400 dots per inch image of a picrosirius red
stained prostate section from subject 3. The histotripsy
treatment cavity is seen to communicate with the urethral
lumen with collagen deposition apparent surrounding the
treatment zone.
814 DARNELL ET AL.
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f M
ic
hi
ga
n 
e-
jou
rna
l p
ack
ag
e f
rom
 on
lin
e.l
ieb
ert
pu
b.c
om
 at
 12
/08
/17
. F
or 
pe
rso
na
l u
se 
on
ly.
 
was treated, allowing the right half to serve as an internal
control in each case.
The image quantification algorithm is subject to an over-
estimation area when calculating the absolute collagen area.
Because collagen fiber widths can be as small as several
nanometers, even the presence of a very small amount of
stained collagen within a pixel will result in it being char-
acterized as a collagen containing pixel. This overestimation
of collagen area will be greatest when assessing low mag-
nification images, which have the largest pixel size. As image
magnification increases, pixel size decreases, and the effect
of overestimation decreases. Nonetheless, when comparing
images of the same magnification, this image analysis algo-
rithm does allow relative comparison of collagen content.
Conclusions
In vivo histotripsy of canine prostate produced a decrease
in prostate volume coupled with a limited inflammatory and
fibrotic response. A narrow (1.5mm) band of fibrosis around
the empty, reepithelialized treatment cavity was observed
6 weeks after treatment. In four cases, an overall reduction in
collagen content was measured after histotripsy. Further
studies are planned to correlate these histologic findings with
alteration in mechanical tissue properties and to explore
histotripsy strategies for treatment of BPH that optimize
tissue volume removal with minimization of fibrosis.
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